Study identifier:311CUS/0016
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Multicenter, Randomized, Open-label Comparison of the effects of Zomig-ZMT TM (Zolmitriptriptan) and Usual Migraine Care on work loss, Productivity, + Patient Preference.
migraine
Phase 4
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|